André Rosenthal

from Wikipedia, the free encyclopedia

André Rosenthal (born  October 11, 1956 in Bad Saarow ) is a German molecular biologist and geneticist who is considered one of the most renowned genome researchers in Germany. From 1993 to 2000 he worked as a professor at the Friedrich Schiller University in Jena and as a department head at the Jena Institute for Molecular Biotechnology, and played a key role in the international human genome project , and has held leading positions in various biotechnology companies since 1997.

Life

André Rosenthal was born in Bad Saarow in 1956 as the son of Hans-Alfred Rosenthal , virologist at the Humboldt University in Berlin , and Sinaida Rosenthal , biochemist at the Central Institute for Molecular Biology in Berlin-Buch . From 1976 to 1981 he studied chemistry at the Humboldt University and received his doctorate in 1983 with a thesis on the synthesis of DNA . He then worked from 1984 to 1989 as a research assistant at the Central Institute for Molecular Biology.

In 1989 he moved to the University of Cambridge , where he worked in the molecular biology laboratory under the direction of Sydney Brenner . In 1993 he took over the management of the department of molecular genome analysis at the non-university institute for molecular biotechnology in Jena as well as a professorship for molecular biology at the Friedrich Schiller University there . The contribution of his working group to the decoding of the DNA sequence of the human chromosome 21 is considered to be the most extensive German contribution and, in an international comparison, the ninth largest contribution to the human genome project .

From 1997 he was also managing director and scientific director of the Berlin biotechnology company MetaGen , a subsidiary of Schering AG , whose goal was the development of drugs against cancer . In June 2000 he gave up his academic duties in Jena and worked exclusively for MetaGen in the following period . At the end of 2003 the company was taken over by the British company Astex Technology , the Berlin headquarters were given up. Since 2004 he has been managing director of Signature Diagnostics in Potsdam , whose main business area is the development of genetic tests for the early detection of cancer.

Works (selection)

  • Influence of the genome project and pharmacogenetics on medical development. Schattauer, Stuttgart and New York 2002 (as editor)
  • The Human Genome: Biology and Medicine. Springer, Berlin, Heidelberg, New York 2002 (as co-editor)
  • Deciphering the Human Genome: Ambivalent Effects on Society and Science. Trafo-Verlag, Berlin 2007 (as co-author)

literature

  • Heinz Horeis: The Gen-Star: André Rosenthal. A researcher became a media event. In: Image of Science . Edition 12/2000 of November 11, 2000, pp. 42-47
  • Dirk Kurbjuweit: Nobody can stop them. Germany's most ambitious genome decoder is André Rosenthal, he wants to be the first to defeat cancer. In: Der Spiegel . Edition 27/2001 of July 2, 2001, pp. 66–70

Web links

personal data
SURNAME Rosenthal, André
BRIEF DESCRIPTION German molecular biologist and geneticist
DATE OF BIRTH October 11, 1956
PLACE OF BIRTH Bad Saarow